Inspired by these findings, we recently demonstrated that AS1411, after selectively entering tumor cells, can recruit MDM2 via forming an NCL-bridged complex, i.e., AS1411-NCL-MDM2 40. This evidence concerns the gene MDM2 and neoplasm.